Latest updates for Adex-No-Bid

Fresh curated links around adex-no-bid are collected here so marketers can spot useful updates and turn timely ideas into posts faster.

Recent items include:

  • Prebid’s Proposed Auction Overhaul Would Do What The Court Wouldn’t: Separate AdX From GAM
  • Primary Markets Group September 2026 U.S. IPO Update
  • Court Declines to Order AdX Divestiture in Google Ad Tech Case

Post angles to try

Share the most useful takeaway for your audience.
Turn one article into a quick practical checklist.
Ask your audience how this shift affects their work.
Turn angles into scheduled posts

Fresh articles and ideas

Recent curated links from global sources. Generate one free draft from any story, then use SocialBu to schedule and refine your content calendar.

adexchanger.com /1 week ago

Prebid’s Proposed Auction Overhaul Would Do What The Court Wouldn’t: Separate AdX From GAM

Last month, a federal court ordered Google to integrate with Prebid but didn’t say how. So Prebid is writing the instructions itself. The organization is moving ahead with a propos...

Read source
seekingalpha.com /2 weeks ago

Primary Markets Group September 2026 U.S. IPO Update

Read source
natlawreview.com /1 month ago

Court Declines to Order AdX Divestiture in Google Ad Tech Case

On September 16, the Eastern District of Virginia unsealed Judge Leonie Brinkema's 106-page remedies opinion in United States v. Google, the Justice Department's ad tech monopoliza...

Read source
biopharmadive.com /1 month ago

RNAi drug specialist ADARx raises $446M IPO

ADARx is the only maker of RNA-based drugs to go public since 2024 and the first RNAi biotech to price an IPO in the U.S. in more than a decade.

Read source

Turn fresh research into a full content calendar

Use SocialBu to discover ideas, generate post drafts, and schedule them across your social channels.

Sources covering Adex-No-Bid

feeds2.feedburner.com

Recent coverage from public sources
Public source

seekingalpha.com

Recent coverage from public sources
Public source

biopharmadive.com

Recent coverage from public sources
Public source

natlawreview.com

Recent coverage from public sources
Public source